Analysis of lung cancer morbidity and mortality in the Republic of Tajikistan for 2016-2022

Abstract

Aim. To study the dynamics of morbidity and mortality from lung cancer in the Republic of Tajikistan for the period 2016-2022.

Materials and methods. A statistical analysis of the incidence and mortality from lung cancer was carried out according to the data of the Republican Center for Medical Statistics and Information of the Ministry of Health and Social Protection of the Population of the Republic of Tajikistan for 2016-2022.

Results of the study and their discussion. The incidence of lung cancer in the Republic of Tajikistan has a relatively slow growth rate and ranks 9th among all malignant tumors, amounting to 3.6%. High rates of lung cancer incidence were noted in age groups 45-54 (18,8%), 55-64 (33%) and over 65 years old, which is 35.8%. Patients from stage I-II make up 52.9%, from stages III-IV - 47.1%. The one-year mortality rate from lung cancer is 28.8-41.2%.

Conclusion. In the Republic of Tajikistan, lung cancer has had a relatively low growth rate over the past 16 years. The highest rates were recorded in 2019 and 2022. Lung cancer is most often suffered by the male population. The peak incidence is over the age of 65, which is 35.8%. The proportion of patients with stages III-IV of the process decreased markedly in 2016- 2022 compared to 2007-2015, respectively from 59.9% to 47.1%. The one-year mortality rate from lung cancer is 28.8-41.2%.